Want to see NRSN full AI Analyst Report?
Neurosense Therapeutics Ltd. (NRSN) Ownership - Who Owns Neurosense Therapeutics Ltd.?
Neurosense Therapeutics Ltd. (NRSN) Ownership Overview
- 18.61% Insiders
- 0.04% Mutual Funds
- 0.21% Other Institutional Investors
- 81.14% Public Companies and Individual Investors
The ownership structure of Neurosense Therapeutics Ltd. (NRSN) stock is a mix of institutional, retail, and individual investors. Approximately 0.25% of the company’s stock is owned by Institutional Investors, 18.61% is owned by Insiders, and 81.14% is owned by Public Companies and Individual Investors.
The ownership structure of Neurosense Therapeutics Ltd. (NRSN) stock is a mix of institutional, retail, and individual investors. Approximately 0.25% of the company’s stock is owned by Institutional Investors, 18.61% is owned by Insiders, and 81.14% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 16, 2026 | Alon Ben-noon | $200,000 | |
| Jun 16, 2026 | Or Eisenberg | $200,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Or Eisenberg | 1,504,050 | Insider | 79.29% | 2,150,792 |
| Hagit Binder | 521,806 | Insider | 27.51% | 746,183 |
| Niva Russek-blum | 467,953 | Insider | 24.67% | 669,173 |
| Fidelity Concord Street Trust | 15,870 | Institution | 0.84% | 22,694 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 15,870 | Institution | 0.84% | 22,694 |
FAQ
Who Owns Neurosense Therapeutics Ltd. (NRSN)?
According to the latest TipRanks data, approximately 0.25% of the company's stock is held by institutional investors, 18.61% is held by insiders, and 81.14% is held by public companies and individual investors.
What percentage of Neurosense Therapeutics Ltd. (NRSN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.25% of Neurosense Therapeutics Ltd. (NRSN) stock is held by institutional investors: 0.04% by mutual funds and 0.21% by other institutional investors.
What percentage of Neurosense Therapeutics Ltd. (NRSN) stock is held by retail investors?
According to the latest TipRanks data, approximately 81.14% of Neurosense Therapeutics Ltd. (NRSN) stock is held by public companies and individual investors.
Who owns the most shares of Neurosense Therapeutics Ltd. (NRSN)?
Or Eisenberg owns the most shares of Neurosense Therapeutics Ltd. (NRSN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
